PARTICIPA

PARTICIPA

domingo, 7 de abril de 2024

Semaglutide in Patients with Obesity-Related Heart Failure and Type 2 Diabetes | New England Journal of Medicine

https://www.nejm.org/doi/full/10.1056/NEJMoa2313917

Enviado desde mi iPhone

No hay comentarios:

Publicar un comentario

Danos tu opinion, enriquece el post.